[Trends in the treatment of rheumatic diseases].
Trotta
F
F
Unità Operativa di Reumatologia, Azienda Ospedaliera S.Anna, Ferrara.
Padovan
M
M
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000145:classification / Q000627:therapeutic use*; D001168:Arthritis / Q000000981:diagnostic imaging / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging / Q000188:drug therapy; D016026:Bone Marrow Transplantation; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006225:Hand / Q000000981:diagnostic imaging; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007719:Knee Joint / Q000000981:diagnostic imaging; D008727:Methotrexate / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy; D010956:Plasmapheresis; D011859:Radiography; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D016861:Cyclooxygenase Inhibitors; D016756:Immunoglobulins, Intravenous; D014409:Tumor Necrosis Factor-alpha; D016572:Cyclosporine; D008727:Methotrexate
Prospettive nel trattamento delle malattie reumatiche.